Authors


Leslie Campbell, MD, FACC

Latest:

Reconsidering Digoxin in Worsening Chronic Heart Failure

Should we give digoxin another look for chronic heart failure?



Eric R. Bates, MD Professor of Internal Medicine University of Michigan Ann Arbor, MI

Latest:

Benefits and Drawbacks of Clopidogrel 600mg Double Loading Dose Versus Newer P2Y12 Receptor Blockers

Prolonged dual antiplatelet therapy With aspirin and clopidogrel is recommended for all patients undergoing percutaneous coronary intervention.




Paul A. Heidenreich, MD, MS2: From the 1Stanford University Hospital, Falk Cardiovascular Research Center, Stanford, CA

Latest:

Are HDL cholesterol levels clinically significant in patients with low LDL cholesterol levels?

There is some debate about whether the risk of cardiovascular events associated with low high-density lipoprotein (HDL) cholesterol levels is attenuated by very low low-density lipoprotein (LDL) cholesterol levels (< 60 mg/dL), which can be obtained with statins and combination therapy.






Timir K. Paul, MD, PhD, MPH, FACC

Latest:

Morphine Decreases Clopidogrel Concentrations and Effects

Is there a clinically significant interaction between morphine and clopidogrel?


Elizabeth Freid Vocke

Latest:

Are Your Patients in Clinical Trials? US Oncology Surveys Oncologists

Participation in clinical trial research is essential to continued improvement in cancer care. Yet, fewer than 10% of U.S. adults enroll in trials. A recent US Oncology�sponsored survey found that most oncologists remain optimistic about the future of clinical trial research. We discuss obstacles to clinical trial enrollment with Nicholas Vogelzang, MD, and Matthew Galsky, MD, of the Comprehensive CancerCenters of Nevada.


W. B. Meijboom, MD

Latest:

High-resolution spiral computed tomography coronary angiography

We evaluated the performance of the 64-slice spiral computed tomography coronary angiography scanner in 52 symptomatic patients with stable sinus rhythm and found that it was highly reliable in ruling out the presence of a significant coronary stenosis. This technique may be regarded as a suitable alternative to invasive coronary angiography.


Patrick Dunegan

Latest:

How GSSI, A Nonprofit, is Fighting Gastroparesis

Patrick Dunegan, Rare Impact Awardee, explains how GSSSI, a 501c3 nonprofit organization, is working to fight gastroparesis, a gastric motility disorder known to be very debilitating for those who suffer from it.


Francisco A. Durazo, MD

Latest:

How Would You Manage This Man With Non-alcoholic Fatty Liver Disease

You see a 48-year-old white man for his annual examination. He is in good health with no major medical problems and an unremarkable medical history. He states he regularly drinks one or two beers a day on the weekend but not usually on weekdays. He denies blood transfusions, tattoos or intravenous drugs. His father had diabetes. Physical examination is notable for the patient being mildly obese with a body mass index of 32.


Catherine Loftus, New York Medical College

Latest:

Alternating Hemiplegia of Childhood: Partnering with the Patient

Since AHC is a rare neurological disease, finding a diagnosis can be a harrowing experience.



Terri Cullen

Latest:

Healthcare "Game Changers" at the 2011 Consumer Electronics Show

Buzz at the CES has focused on smartphones, 3-D TVs, and new tablets, but companies are unveiling game changing technologies in health care.





Sidney C. Smith, Jr, MD, University of North Carolina School of Medicine, Chapel Hill

Latest:

Improving Your Patients' Adherence to Statin Therapy

Despite the proven benefits of lipid-lowering therapy, many patients stop taking their prescribed medications. Follow these practical tips to increase patients' compliance.


Alan G. Wasserman, MD is professor

Latest:

Significance of hyperglycemia and platelet function in diabetic patients

Glucose-insulin-potassium (GIK) was initially advocated as a treatment of acute myocardial infarction (MI) to promote electrical stability.



Julia Song, MD

Latest:

Glaucoma: The Silent Killer of Eyesight

Glaucoma is a leading cause of blindness in the United States. The 2 main types of glaucoma are open-angle and narrow-angle. Glaucoma damages the optic nerve, typically resulting in loss of peripheral vision, which eventually progresses to involve the central visual field. Because patients with glaucoma are usually asymptomatic, primary care physicians can play a vital role in recognizing this silent cause of blindness. The goal of treatment, which consists of eye drops, laser trabeculoplasty, or surgery, is to lower intraocular pressure. Eye drops are effective but can have local as well as systemic side effects. Early recognition in the primary care setting and timely referral to ophthalmologists can prevent permanent vision loss.


Ziad Sara, MD, FASN

Latest:

Insight into a Forgotten Disease: Lemierre's Syndrome

Lemierre's syndrome is characterized by oropharyngeal infection, usually by Fusobacterium necrophorum, followed by septic thrombophlebitis of the internal jugular vein with embolization to the lungs and other organs. Since the introduction of antibiotics, Lemierre's syndrome has become relatively rare and is usually unsuspected until blood culture results are available. In the preantibiotic era, ligation of the internal jugular vein on the affected side to prevent septicemia was the only recognized treatment. Current therapy is a 4- to 6-week course of antibiotics, such as penicillin G, clindamycin, or metronidazole, directed against F necrophorum. The use of anticoagulation is still controversial.


Christoph U. Lehmann, MD

Latest:

Clinical Decision Support: Information overload can be a prescription for bad medicine

The push for clinical decision support technology in medicine is a logical consequence of our experiences.


DrRich

Latest:

Medical Ethics and the Amish Bus Driver Rule

In which the author expounds upon the dangers posed by Progressive medical ethics.



Ryan Gray, MD

Latest:

The 10 Worst Things Patients Can Say to Physicians

Most patients are well-meaning and generally nice. But every now and then, you will get one who is a total pain to deal with. Maybe your patient lies to you, gets sarcastic, asks for special “favors,†or generally just pushes your buttons. We’ve all been there.

© 2024 MJH Life Sciences

All rights reserved.